Jeffrey Ferrell

Jeffrey A. Ferrell is the founder and Managing Partner of Athyrium Capital Management, LP, a firm he established in 2008.13 With extensive experience in the life sciences sector, Ferrell has built a career focused on investments across various asset classes and transaction structures.1

Professional Background

Before founding Athyrium, Ferrell held several positions at Lehman Brothers, including:

• Overseeing life sciences investments for Global Trading Strategies
• Vice President in Lehman Brothers' Private Equity division, focusing on life sciences investments1

Prior to his time at Lehman Brothers, which began in 2001, Ferrell served as Principal at Schroder Ventures Life Sciences (SVLS) in Boston.1

Investment Experience

Ferrell has been involved in numerous notable investments throughout his career, including:

• Sequenom
• Bioenvision (acquired by Genzyme)
• Jazz Pharmaceuticals
• Orthovita (acquired by Stryker)
• Nektar Therapeutics
• ISTA Pharmaceuticals
• Auxilium Pharmaceuticals
• Fluidigm1

Education

Jeffrey Ferrell graduated from Harvard College with an AB in Biochemical Sciences.1

Current Role

As Managing Partner at Athyrium Capital Management, LP, Ferrell leads the firm's investment team.2 His expertise in life sciences investments continues to shape the firm's strategy and portfolio management.

Jeffrey Ferrell's LinkedIn profile confirms his current position as Managing Partner at Athyrium Capital Management, LP, and indicates that he has over 500 connections on the platform.4